Current Treatment Options in Oncology

Papers
(The H4-Index of Current Treatment Options in Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers163
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer113
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia85
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies72
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma60
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead55
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes53
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect51
Whole Abdominal Radiotherapy in Bone and Soft Tissue Sarcomas: Indications, Techniques, Clinical Outcomes, and Future Directions48
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer47
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?42
An Update on Temporal Bone Paragangliomas42
Management of Fatigue in Patients with Advanced Cancer40
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers40
Approach to Localized Squamous Cell Cancer of the Esophagus39
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors34
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma34
Small Cell Lung Cancer—An Update on Chemotherapy Resistance33
The Role of Nursing in the Delivery of Cardio-Oncology32
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer32
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer32
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities31
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations29
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements29
Advances in Targeted Therapy for Metastatic Prostate Cancer28
Regorafenib for the Treatment of Sarcoma28
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs27
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?27
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia27
0.29488921165466